Using a smartphone app to help patients with alcohol-related liver disease stop drinking.
Official title: Testing an mHealth System for Integrating Alcohol Use Treatment with Hepatology Care for Patients with Alcohol-associated Liver Disease
Funded at University of Wisconsin-Madison · NIH-10932395 · Data updated 2026-11-12
This study is testing a smartphone app that helps people with alcohol-related liver disease cut down on drinking, and it’s designed for patients who want extra support alongside their regular medical care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | September 20, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $617,700 |
| NIH project number | 5R01AA030470-02 |
| Project ID | NIH-10932395 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with alcohol-associated liver disease who are seeking help to reduce or stop their alcohol consumption.
✕Less likely to help
Patients who are not diagnosed with alcohol-associated liver disease or those who are not interested in reducing their alcohol intake may not benefit from this research.
What this research studies
This research investigates the effectiveness of a smartphone application designed to support alcohol cessation in patients with alcohol-associated liver disease (ALD). It aims to integrate alcohol use treatment with hepatology care, addressing the significant gap in treatment access for ALD patients. The study will involve a randomized, controlled trial where patients will receive the app alongside their regular medical care to evaluate its impact on reducing alcohol consumption. By focusing on both behavioral intervention and medical treatment, the research seeks to improve patient outcomes and reduce the burden of ALD.
Why it matters
Potential benefit: If successful, this research could significantly improve access to effective alcohol cessation treatment for patients with alcohol-associated liver disease.
How similar studies have gone: Previous research has shown that integrated behavioral interventions for alcohol cessation can be effective, suggesting a promising avenue for this approach.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Quanbeck, Andrew — University of Wisconsin-Madison
- Study coordinator: Quanbeck, Andrew
Related research
Other NIH-funded projects on the same topics.
-
Biomarkers to detect recent heavy drinking in veterans
A doctor-scientist team is testing blood biomarkers to better identify recent excessive alcohol use in veterans so clinicians can screen, counsel, and care for those at risk.
-
Understanding how heavy drinking and anxiety relate in emerging adults
This grant studies how heavy alcohol use and anxiety symptoms interact in young adults (ages 18–34) and what biological stress markers might reveal about that relationship.
-
Understanding how veterans access care for alcohol use and behavioral health
A study following 2,000 post-9/11 veterans to see how alcohol use, PTSD, and depression relate to access to behavioral health care over four years.
-
Understanding how peer norms around alcohol and HIV prevention affect adolescents and young adults in rural Uganda
This project studies how what young people think their peers do or approve of influences drinking and HIV prevention behaviors in rural Uganda, with the goal of improving health outcomes.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
-
Functional Connectivity-Guided TMS for Alcohol Use Disorder
A new approach uses targeted brain stimulation to help people with alcohol use disorder stay abstinent longer by focusing treatment on specific brain circuits.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.